0173-0866 : Tanzeum 30 mg/.5ml Subcutaneous Injection, Powder, Lyophilized, for Solution

Labeler: Glaxosmithkline LLC
Product Type: Human Prescription Drug
Drug Name:  Tanzeum
Dosage Form: Subcutaneous Injection, Powder, Lyophilized, for Solution
Application #: BLA125431
Rev. Date: 

NDC Package Codes:

  • 0173-0866-02: 1 SYRINGE IN 1 CARTON (0173‑0866‑02) > .5 ML IN 1 SYRINGE
  • 0173-0866-35: 4 SYRINGE IN 1 CARTON (0173‑0866‑35) > .5 ML IN 1 SYRINGE
  • 0173-0866-61: 1 SYRINGE IN 1 CARTON (0173‑0866‑61) > .5 ML IN 1 SYRINGE

Active Ingredients:

  • Albiglutide

Dosage Strength:

  • 30 mg/.5mL

Pharmaceutical Classes:

  • GLP-1 Receptor Agonist [EPC]
  • Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]

Related Products:

Based on records with the same trade name.
  • 0173-0867 Tanzeum 50 mg/.5ml Subcutaneous Injection, Powder, Lyophilized, for Solution by Glaxosmithkline LLC


Scan the QR code below to easily reference this data in the future:

NDC 0173-0866 QR Code

< Prev: 0173-0864Next: 0173-0867 >

Related Discussions:

Been it a week and now my blood sugars are higher, and I tried to call them and they will not return my calls, so tell m... 49 replies
Tanzeum Side Effects?
Anyone have any severe side effects? ## Hello, Rich! How are you? What types of side effects are you experiencing? The m... 16 replies
tanzeum when to use
i just started tanzeum and my numbers are just a little too low for me around 95-105 AFTER eating so i wondering if i ta... 2 replies
severe side effects from tanzeum
I was pre diabetic and my dr prescribed Tanzeum I took 5 week shots of Tanzeum and did not seam to have problems, I thou... 1 reply

Note: The MedsChat® NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.